Qiao Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qiao Yu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Lijing Wang
Department of Geriatrics, Xiangya Hospital, Central South University, National Clinical Research Center for Geriatric Disorders(Xiangya Hospital), Changsha, China
2 shared publications - Qiong Chen
Department of Geriatric Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, China
2 shared publications Expert Committee of Consensus Opinion on Influenza Vaccine and Pneumococcal Vaccine Vaccination for Elderly People with Chronic Respiratory Diseases, Respiratory Group of Chinese Geriatrics Society
1 shared publication- Hongjun Zhao
Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha 410008, China
1 shared publication - Jian Xiao
Department of Geriatric Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, China
1 shared publication - Min Fang
College of Pharmacy, Changsha Medical University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 13 August 2026
- Published by Wiley in Aging Medicine
- Vol. 9 (4) , 343-354
Expert Consensus on Influenza Vaccine and Pneumococcal Vaccination in Elderly People With Chronic Respiratory Diseases (2024)
Chronic respiratory diseases pose a serious threat to the health of the population due to their high incidence, high disability rate, and poor prognosis. It is necessary to improve the prevention and treatment status of chronic respiratory diseases. Vaccination against influenza and pneumococcal infections can reduce the risk of respiratory infections, lower hospitalization and mortality rates, and alleviate disease burden in individuals with chronic respiratory diseases. However, insufficient public awareness of influenza and pneumococcal vaccines and the lack of recommendation by medical personnel have led to the low actual vaccination rate of influenza and pneumococcal vaccines in elderly people with chronic respiratory diseases in China. Based on existing research evidence both domestically and internationally, this consensus describes the burden of influenza and pneumococcal diseases in elderly people with chronic respiratory diseases, the protective effect and safety of influenza and pneumococcal vaccines, and vaccination recommendations, aiming to promote the vaccination rate of elderly people with chronic respiratory diseases, better play the role of vaccines in preventing influenza and pneumococcal diseases, and reduce the occurrence of respiratory infections and related serious complications in the population with chronic respiratory diseases.
- 13 August 2026
- Published by Wiley in Aging Medicine
- Vol. 9 (4) , 343-354
Open AccessExpert Consensus on Influenza Vaccine and Pneumococcal Vaccination in Elderly People With Chronic Respiratory Diseases (2024)
Chronic respiratory diseases pose a serious threat to the health of the population due to their high incidence, high disability rate, and poor prognosis. It is necessary to improve the prevention and treatment status of chronic respiratory diseases. Vaccination against influenza and pneumococcal infections can reduce the risk of respiratory infections, lower hospitalization and mortality rates, and alleviate disease burden in individuals with chronic respiratory diseases. However, insufficient public awareness of influenza and pneumococcal vaccines and the lack of recommendation by medical personnel have led to the low actual vaccination rate of influenza and pneumococcal vaccines in elderly people with chronic respiratory diseases in China. Based on existing research evidence both domestically and internationally, this consensus describes the burden of influenza and pneumococcal diseases in elderly people with chronic respiratory diseases, the protective effect and safety of influenza and pneumococcal vaccines, and vaccination recommendations, aiming to promote the vaccination rate of elderly people with chronic respiratory diseases, better play the role of vaccines in preventing influenza and pneumococcal diseases, and reduce the occurrence of respiratory infections and related serious complications in the population with chronic respiratory diseases.
- Top Cited PapersOpen Access
- 1 January 2024
- Published by XMLink in Immune Network
- Vol. 24 (2) , e3
Cigarette Smoke Extract-Treated Mouse Airway Epithelial Cells-Derived Exosomal LncRNA MEG3 Promotes M1 Macrophage Polarization and Pyroptosis in Chronic Obstructive Pulmonary Disease by Upregulating TREM-1 via m6A Methylation
Wang L, et al. Immune Netw. 2024 Jan;24(2):e3. https://doi.org/10.4110/in.2024.24.e3
- 1 January 2024
- Published by XMLink in Immune Network
- Vol. 24 (2) , e3
Top Cited PapersOpen AccessCigarette Smoke Extract-Treated Mouse Airway Epithelial Cells-Derived Exosomal LncRNA MEG3 Promotes M1 Macrophage Polarization and Pyroptosis in Chronic Obstructive Pulmonary Disease by Upregulating TREM-1 via m6A Methylation
Wang L, et al. Immune Netw. 2024 Jan;24(2):e3. https://doi.org/10.4110/in.2024.24.e3